The growth of the Indian metallic packaging industry is highly dependent on the progress made by the overall economy. With the country’s economy doing fairly well, the retail sector booming, and consumer awareness on the recycling and environmental benefits of tinplate packaging rising, the outlook for the industry looks positive.
Par Specialty Pharmaceuticals, a division of Par Pharmaceutical, Inc., announced the launch of Cortisporin-TC otic suspension (colistin sulfate - neomycin sulfate - thonzonium bromide - hydrocortisone acetate otic suspension).
A new study says Soy supplements does not improve lung function for patients with asthma. This study is contrary to previous findings suggesting a link between soy intake and decreased asthma severity.
Glenmark Pharmaceuticals granted tentative approval by the US health regulator to sell Rufinamide, which is used to treat seizures caused by Lennox-Gastaut syndrome.
DeNovo Sciences, Inc., an innovator of cutting edge products of liquid biopsy, sign an agreement with START (South Texas Accelerated Research Therapeutics), a San Antonio based phase I medical oncology programme, one of the world’s largest of its kind with clinical trial sites on three continents. As per agreement, START will collect blood samples of cancer patients and use DeNovo instruments and reagents for circulating tumour cells (CTC) enrichment and purification. This will further will then be sent to a large genomics lab for whole genome sequencing. In addition, START and DeNovo have signed a separate agreement to test the ability of Denovo CTC platform to capture CTCs for use in patient derived xenograft (PDX) mice models for drug discovery and biomarker development purposes.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
